Additionally, RGS1 gene-silenced NCIN87-DR cell immunization could also strengthen the inhibitive effect of T-mab on tumor growth (tumor size) when compared with that of mice in NCIN87-DR+T-mab group (Figure 5B, p < 0.05). This evidence concerns the gene RGS1 and neoplasm.